Iffeldorf, Germany

Thomas Emrich

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 72(Granted Patents)


Location History:

  • Iffeldorf, DE (2001 - 2023)
  • Penzberg, DE (2023)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Thomas Emrich: A Vanguard in Antibody Innovation

Introduction

Thomas Emrich, an esteemed inventor based in Iffeldorf, Germany, has made significant strides in the field of biopharmaceuticals with an impressive portfolio of 11 patents. His innovative methodologies focus primarily on antibody selection and characterization, which are critical for advancing therapeutic applications.

Latest Patents

Among Thomas Emrich's leading inventions is a groundbreaking "Antibody selection method." This patent outlines a systematic approach for selecting antibodies with a clearance level in cynomolgus monkeys of less than 8 mL/kg/day. The method involves intricate steps including measuring retention times on FcRn affinity chromatography and heparin affinity chromatography under controlled gradients. By establishing specific relative retention time benchmarks, the invention effectively narrows down candidates for further development.

Another notable patent is for "Humanized anti-Tau(pS422) antibodies and methods of use." This invention provides a new class of humanized antibodies targeting the human tau protein, especially relevant in the context of neurodegenerative diseases, thereby opening up new avenues for therapeutic interventions.

Career Highlights

Thomas Emrich has gained valuable experience working with prestigious organizations such as Roche Diagnostics GmbH and Hoffmann-La Roche Inc. His contributions to these companies have solidified his reputation as a leading figure in the antibody research sector. His work has not only enhanced the understanding of antibody mechanisms but also pushed boundaries in therapeutic development.

Collaborations

Throughout his career, Thomas has collaborated with notable peers, including Ekkehard Moessner and Hubert Kettenberger. These collaborations reflect the synergy that is often essential in pioneering innovative scientific advancements.

Conclusion

In conclusion, Thomas Emrich stands out as a pivotal inventor in the field of antibody research. His commitment to developing advanced methodologies and innovative therapeutics makes him a significant contributor to the biopharmaceutical industry. With 11 patents to his name and ongoing collaborations with industry leaders, Emrich continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…